ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Ben Orwel
|
38K |
17M |
1 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Ben Orwel
|
38K |
17M |
5 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
38K
|
17M
|
5
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Ben Orwel
|
38K |
17M |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Ben Orwel
|
38K |
17M |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
38K
|
17M
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Ben Orwel
|
38K |
17M |
15 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
38K
|
17M
|
15
|
|
ASX - By Stock
|
RSG |
Re:
News: RSG Resolute Mining Says Mining Lease For Bibiani Gold Mine Terminated
|
|
Ben Orwel
|
136 |
70K |
1 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
136
|
70K
|
1
|
|
ASX - By Stock
|
HZR |
Re:
Price action
|
|
Ben Orwel
|
3.5K |
1.5M |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
3.5K
|
1.5M
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Price action
|
|
Ben Orwel
|
3.5K |
1.5M |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
3.5K
|
1.5M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Ben Orwel
|
10K |
3.0M |
0 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
Ben Orwel
|
183 |
94K |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
Ben Orwel
|
183 |
94K |
0 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
Ben Orwel
|
183 |
94K |
5 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Ben Orwel
|
1.0K |
517K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
1
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Change in substantial holding from MIN
|
|
Ben Orwel
|
18 |
5.3K |
3 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
18
|
5.3K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Ben Orwel
|
1.0K |
418K |
2 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Ben Orwel
|
635 |
277K |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
277K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
Ben Orwel
|
8 |
3.2K |
2 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
8
|
3.2K
|
2
|
|
ASX - By Stock
|
FBR |
Re:
Ann: Appendix 2A
|
|
Ben Orwel
|
11 |
4.5K |
1 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
11
|
4.5K
|
1
|
|
ASX - By Stock
|
MVF |
Re:
Ann: Change of Director's Interest Notice
|
|
Ben Orwel
|
1 |
731 |
0 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
1
|
731
|
0
|
|
ASX - By Stock
|
WND |
Re:
Ann: Indicative proposal from Federation to Acquire 100% of WND
|
|
Ben Orwel
|
5 |
15K |
2 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
5
|
15K
|
2
|
|
ASX - By Stock
|
WND |
Re:
News: WND Windlab Says Plans To Exit North American Market
|
|
Ben Orwel
|
3 |
2.1K |
0 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
3
|
2.1K
|
0
|
|
ASX - By Stock
|
WND |
Re:
News: WND Windlab Says Plans To Exit North American Market
|
|
Ben Orwel
|
3 |
2.1K |
1 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
3
|
2.1K
|
1
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Ben Orwel
|
932 |
1.1M |
2 |
14/12/19 |
14/12/19 |
Charts
|
932
|
1.1M
|
2
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Ben Orwel
|
932 |
1.1M |
4 |
13/12/19 |
13/12/19 |
Charts
|
932
|
1.1M
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - J Fairley
|
|
Ben Orwel
|
5 |
3.8K |
2 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
5
|
3.8K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
HZR - Corporate Spotlight.
|
|
Ben Orwel
|
83 |
32K |
4 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
83
|
32K
|
4
|
|
ASX - By Stock
|
HZR |
Re:
HZR - Corporate Spotlight.
|
|
Ben Orwel
|
83 |
32K |
2 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
83
|
32K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Ammonia
|
|
Ben Orwel
|
10 |
3.8K |
2 |
26/10/19 |
26/10/19 |
ASX - By Stock
|
10
|
3.8K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
New interview with Alan Kohler
|
|
Ben Orwel
|
25 |
9.3K |
5 |
26/10/19 |
26/10/19 |
ASX - By Stock
|
25
|
9.3K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Appendix 3B
|
|
Ben Orwel
|
10 |
5.2K |
3 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
10
|
5.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Appendix 3B
|
|
Ben Orwel
|
10 |
5.2K |
2 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
10
|
5.2K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Recapitalisation Progress Update
|
|
Ben Orwel
|
6 |
4.5K |
1 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
6
|
4.5K
|
1
|
|
ASX - By Stock
|
FBR |
Re:
$1/2 Trillion profit, 3000HX robots
|
|
Ben Orwel
|
61 |
32K |
1 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
61
|
32K
|
1
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Recapitalisation Progress Update
|
|
Ben Orwel
|
6 |
4.5K |
2 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
6
|
4.5K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Recapitalisation Progress Update
|
|
Ben Orwel
|
6 |
4.5K |
1 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
6
|
4.5K
|
1
|
|
ASX - By Stock
|
FBR |
Re:
Humaniod Construction Robots
|
|
Ben Orwel
|
20 |
6.1K |
1 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
20
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma to present at US Drug Delivery Conference
|
|
Ben Orwel
|
8 |
3.6K |
8 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
8
|
3.6K
|
8
|
|
ASX - By Stock
|
FBR |
Re:
SP activity
|
|
Ben Orwel
|
562 |
255K |
4 |
06/10/19 |
06/10/19 |
ASX - By Stock
|
562
|
255K
|
4
|
|
ASX - By Stock
|
WND |
Re:
Ann: Becoming a substantial holder
|
|
Ben Orwel
|
4 |
3.4K |
2 |
24/09/19 |
24/09/19 |
ASX - By Stock
|
4
|
3.4K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Recapitalisation Presentation
|
|
Ben Orwel
|
6 |
5.8K |
1 |
07/08/19 |
07/08/19 |
ASX - By Stock
|
6
|
5.8K
|
1
|
|
ASX - By Stock
|
TTT |
Re:
TTT lack of revenue
|
|
Ben Orwel
|
10 |
6.3K |
1 |
19/07/19 |
19/07/19 |
ASX - By Stock
|
10
|
6.3K
|
1
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Corporate Update
|
|
Ben Orwel
|
1 |
2.4K |
2 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
1
|
2.4K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Change of Address
|
|
Ben Orwel
|
32 |
9.7K |
2 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
32
|
9.7K
|
2
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Change of Auditor
|
|
Ben Orwel
|
5 |
2.8K |
0 |
27/06/19 |
27/06/19 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
WND |
Re:
Ann: Full Year Statutory Accounts - Year Ended 31 December 2018
|
|
Ben Orwel
|
20 |
8.7K |
0 |
26/06/19 |
26/06/19 |
ASX - By Stock
|
20
|
8.7K
|
0
|
|
ASX - By Stock
|
WND |
Re:
Ann: Full Year Statutory Accounts - Year Ended 31 December 2018
|
|
Ben Orwel
|
20 |
8.7K |
0 |
26/06/19 |
26/06/19 |
ASX - By Stock
|
20
|
8.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Economic Burden In Steroid-Refractory aGVHD
|
|
Ben Orwel
|
5 |
3.4K |
0 |
18/06/19 |
18/06/19 |
ASX - By Stock
|
5
|
3.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Okamoto launches VivaGel condom in Japan
|
|
Ben Orwel
|
23 |
13K |
0 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
23
|
13K
|
0
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Update on Voluntary Administration
|
|
Ben Orwel
|
23 |
18K |
1 |
29/05/19 |
29/05/19 |
ASX - By Stock
|
23
|
18K
|
1
|
|
ASX - By Stock
|
FBR |
Re:
Ann: FBR Appendix 3B
|
|
Ben Orwel
|
14 |
6.2K |
4 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
14
|
6.2K
|
4
|
|